Keith Lamont Cummings - Dec 22, 2022 Form 4 Insider Report for PLIANT THERAPEUTICS, INC. (PLRX)

Role
Chief Financial Officer
Signature
/s/ Mike Ouimette, attorney-in-fact
Stock symbol
PLRX
Transactions as of
Dec 22, 2022
Transactions value $
$8,320
Form type
4
Date filed
12/27/2022, 03:30 PM
Previous filing
Dec 21, 2022
Next filing
Jan 25, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PLRX Common Stock Options Exercise $8.32K +4K +4.97% $2.08* 84.4K Dec 22, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PLRX Stock Option (right to buy) Options Exercise $0 -4K -2.66% $0.00 146K Dec 22, 2022 Common Stock 4K $2.08 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to such option vested on December 31, 2019 and 1/48th of the shares subject to the option vest in substantially equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.